BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 32202684)

  • 1. Universal chromosomal microarray analysis reveals high proportion of copy-number variants in low-risk pregnancies.
    Stern S; Hacohen N; Meiner V; Yagel S; Zenvirt S; Shkedi-Rafid S; Macarov M; Valsky DV; Porat S; Yanai N; Frumkin A; Daum H
    Ultrasound Obstet Gynecol; 2021 May; 57(5):813-820. PubMed ID: 32202684
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical utility of expanded non-invasive prenatal screening and chromosomal microarray analysis in high-risk pregnancy.
    Zhu X; Chen M; Wang H; Guo Y; Chau MHK; Yan H; Cao Y; Kwok YKY; Chen J; Hui ASY; Zhang R; Meng Z; Zhu Y; Leung TY; Xiong L; Kong X; Choy KW
    Ultrasound Obstet Gynecol; 2021 Mar; 57(3):459-465. PubMed ID: 32198896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of prenatal renal ultrasound abnormalities with pathogenic copy number variants in a large Chinese cohort.
    Su J; Qin Z; Fu H; Luo J; Huang Y; Huang P; Zhang S; Liu T; Lu W; Li W; Jiang T; Wei S; Yang S; Shen Y
    Ultrasound Obstet Gynecol; 2022 Feb; 59(2):226-233. PubMed ID: 34090309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dilemmas in genetic counseling for low-penetrance neuro-susceptibility loci detected on prenatal chromosomal microarray analysis.
    Brabbing-Goldstein D; Reches A; Svirsky R; Bar-Shira A; Yaron Y
    Am J Obstet Gynecol; 2018 Feb; 218(2):247.e1-247.e12. PubMed ID: 29146387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal microarray should be performed for cases of fetal short long bones detected prenatally.
    Tzadikevitch Geffen K; Singer A; Maya I; Sagi-Dain L; Khayat M; Ben-Shachar S; Daum H; Michaelson-Cohen R; Feingold-Zadok M; Sukenik Halevy R
    Arch Gynecol Obstet; 2021 Jan; 303(1):85-92. PubMed ID: 32761367
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical utility of expanded non-invasive prenatal screening compared with chromosomal microarray analysis in over 8000 pregnancies without major structural anomaly.
    Maya I; Salzer Sheelo L; Brabbing-Goldstein D; Matar R; Kahana S; Agmon-Fishman I; Klein C; Gurevitch M; Basel-Salmon L; Sagi-Dain L
    Ultrasound Obstet Gynecol; 2023 Jun; 61(6):698-704. PubMed ID: 36776119
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Implication of chromosomal microarray analysis prior to in-utero repair of fetal open neural tube defect.
    Zemet R; Krispin E; Johnson RM; Kumar NR; Westerfield LE; Stover S; Mann DG; Castillo J; Castillo HA; Nassr AA; Sanz Cortes M; Donepudi R; Espinoza J; Whitehead WE; Belfort MA; Shamshirsaz AA; Van den Veyver IB
    Ultrasound Obstet Gynecol; 2023 Jun; 61(6):719-727. PubMed ID: 36610024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chromosomal microarray vs. NIPS: analysis of 5541 low-risk pregnancies.
    Sagi-Dain L; Cohen Vig L; Kahana S; Yacobson S; Tenne T; Agmon-Fishman I; Klein C; Matar R; Basel-Salmon L; Maya I
    Genet Med; 2019 Nov; 21(11):2462-2467. PubMed ID: 31123319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive evaluation of genetic variants using chromosomal microarray analysis and exome sequencing in fetuses with congenital heart defect.
    Qiao F; Wang Y; Zhang C; Zhou R; Wu Y; Wang C; Meng L; Mao P; Cheng Q; Luo C; Hu P; Xu Z
    Ultrasound Obstet Gynecol; 2021 Sep; 58(3):377-387. PubMed ID: 33142350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of chromosome microarray analysis in prenatal diagnosis.
    Xia M; Yang X; Fu J; Teng Z; Lv Y; Yu L
    BMC Pregnancy Childbirth; 2020 Nov; 20(1):696. PubMed ID: 33198662
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromosomal microarray analysis as a first-line test in pregnancies with a priori low risk for the detection of submicroscopic chromosomal abnormalities.
    Fiorentino F; Napoletano S; Caiazzo F; Sessa M; Bono S; Spizzichino L; Gordon A; Nuccitelli A; Rizzo G; Baldi M
    Eur J Hum Genet; 2013 Jul; 21(7):725-30. PubMed ID: 23211699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microarray and RASopathy-disorder testing in fetuses with increased nuchal translucency.
    Sinajon P; Chitayat D; Roifman M; Wasim S; Carmona S; Ryan G; Noor A; Kolomietz E; Chong K
    Ultrasound Obstet Gynecol; 2020 Mar; 55(3):383-390. PubMed ID: 31115076
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prenatal diagnosis of chromosomal abnormalities in fetuses with abnormal cardiac ultrasound findings: evaluation of chromosomal microarray-based analysis.
    Mademont-Soler I; Morales C; Soler A; Martínez-Crespo JM; Shen Y; Margarit E; Clusellas N; Obón M; Wu BL; Sánchez A
    Ultrasound Obstet Gynecol; 2013 Apr; 41(4):375-82. PubMed ID: 23233332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of copy number variants with chromosomal microarray in 10 377 pregnancies at a single laboratory.
    Lin YH; Jong YJ; Huang PC; Tsai C
    Acta Obstet Gynecol Scand; 2020 Jun; 99(6):775-782. PubMed ID: 32346853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoplastic nasal bone: A potential marker for facial dysmorphism associated with pathogenic copy number variants on microarray.
    Gu YZ; Nisbet DL; Reidy KL; Palma-Dias R
    Prenat Diagn; 2019 Jan; 39(2):116-123. PubMed ID: 30578730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of copy number variations associated with congenital heart disease by chromosomal microarray analysis and next-generation sequencing.
    Zhu X; Li J; Ru T; Wang Y; Xu Y; Yang Y; Wu X; Cram DS; Hu Y
    Prenat Diagn; 2016 Apr; 36(4):321-7. PubMed ID: 26833920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical value of genome-wide high resolution chromosomal microarray analysis in etiological study of fetuses with congenital heart defects].
    Wu X; Fu F; Li R; Pan M; Han J; Zhen L; Yang X; Zhang Y; Li F; Liao C
    Zhonghua Fu Chan Ke Za Zhi; 2014 Dec; 49(12):893-8. PubMed ID: 25608988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. What have we learned from 691 prenatal chromosomal microarrays for ventricular septal defects?
    Maya I; Singer A; Yonath H; Reches A; Rienstein S; Zeligson S; Ben Shachar S; Sagi-Dain L
    Acta Obstet Gynecol Scand; 2020 Jun; 99(6):757-764. PubMed ID: 31424084
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A two-year prospective study assessing the performance of fetal chromosomal microarray analysis and next-generation sequencing in high-risk pregnancies.
    Ridnõi K; Muru K; Keernik M; Pajusalu S; Ustav EL; Tammur P; Mölter-Väär T; Kahre T; Šamarina U; Asser K; Szirko F; Reimand T; Õunap K
    Mol Genet Genomic Med; 2021 Oct; 9(10):e1787. PubMed ID: 34486251
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of prenatal chromosomal microarray: prospective cohort study and systematic review and meta-analysis.
    Hillman SC; McMullan DJ; Hall G; Togneri FS; James N; Maher EJ; Meller CH; Williams D; Wapner RJ; Maher ER; Kilby MD
    Ultrasound Obstet Gynecol; 2013 Jun; 41(6):610-20. PubMed ID: 23512800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.